SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-17-000027
Filing Date
2017-04-05
Accepted
2017-04-05 16:13:11
Documents
1
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149142317579239.html 4  
1 FORM 4 wf-form4_149142317579239.xml 4 3944
  Complete submission text file 0001485003-17-000027.txt   5324
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
MCCABE JOHN J (Reporting) CIK: 0001205535 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 17742706

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations